Advertisement

NeuroDyne Medical Corp. of Cambridge has received a letter of intent from Zynex Inc. of Colorado which plans to buy substantially all of the assets of NeuroDyne, for undisclosed terms.

In a release put out today, Zynex (OTCBB: ZYXI) said it would make the acquisition through its subsidiary Zynex NeuroDiagnostics Inc. NeuroDyne is manufacturer of medical instruments, sensors, disposable electrodes and software that offer sEMG, EKG, EEG, respiration, skin temp, EDR, EDL, peripheral blood flow, IBI, heart rate, and heart rate variability. Zynex, in turn, is a developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, the company said.

SOURCE

Advertisement
Advertisement